Role of Hydrogen Sulfide in Myocardial Ischemia–Reperfusion Injury-Reference-Cited by-全球学者库

Role of Hydrogen Sulfide in Myocardial Ischemia–Reperfusion Injury

Published:2021-02 Issue:2 Volume:77 Page:130-141
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:

Author:

Zhang Peng,Yu Yue,Wang Pei,Shen Hua,Ling Xinyu,Xue Xiaofei,Yang Qian,Zhang Yufeng,Xiao Jian,Wang Zhinong

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference145 articles.

1. A review of hydrogen sulfide (H2S) donors: chemistry and potential therapeutic applications;Powell;Biochem Pharmacol.,2018

2. A long-term and slow-releasing hydrogen sulfide donor protects against myocardial ischemia/reperfusion injury;Sun;Sci Rep.,2017

3. Isoflurane reduces pain and inhibits apoptosis of myocardial cells through the phosphoinositide 3-kinase/protein kinase B signaling pathway in mice during cardiac surgery;Pi;Mol Med Rep.,2018

4. Cardioprotection of tilianin ameliorates myocardial ischemia-reperfusion injury: role of the apoptotic signaling pathway;Zeng;PLoS One.,2018

5. Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease;Polhemus;Circ Res.,2014

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of H2S-donor ascorbic acid derivative and ischemia/reperfusion-induced injury in isolated rat hearts;European Journal of Pharmaceutical Sciences;2024-02

2. Pharmacological interventions targeting the microcirculation following traumatic spinal cord injury;Neural Regeneration Research;2024-01

3. Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotection;Redox Biology;2023-11

4. Effects of scutellarin on acute myocardial ischemia/reperfusion injury in isolated rat heart;European Journal of Inflammation;2023-08-07

5. Protection of H2S against Hypoxia/Reoxygenation Injury in Rat Hippocampal Neurons through Inhibiting Phosphorylation of ROCK2 at Thr436 and Ser575;Pharmaceuticals;2023-01-31